Relmada Therapeutics RLMD
NASDAQ RLMD
$3.77 +0.04 (+1.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) FCF Margin (2012 - 2013)

Updated

Relmada Therapeutics' FCF Margin came in at -196.12% for FY2013, down 100.86 percentage points from -95.27% in FY2012.

Analysis

Relmada Therapeutics (RLMD) FCF Margin (2012 - 2013) Analysis & Trends

  • Per Business Quant, earlier years put FCF Margin at -95.27% in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.82%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 18.33%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 26.96%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 43.05%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 34.72%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.70%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 44.00%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 30.39%
10 Relmada Therapeutics 402.15 Mn 402.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2013 -493.19%
Feb 28, 2013 327.32%
Nov 30, 2012 69.66%
Aug 31, 2012 -220.73%
May 31, 2012 -496.50%
API Access

Relmada Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=RLMD&period=max&api_key=YOUR_API_KEY